IOL CHEMICALS & PHARM. | SANDU PHARMA | IOL CHEMICALS & PHARM./ SANDU PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | 52.7 | 26.1% | View Chart |
P/BV | x | 1.6 | 1.5 | 102.7% | View Chart |
Dividend Yield | % | 1.0 | 1.2 | 82.2% |
IOL CHEMICALS & PHARM. SANDU PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SANDU PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ SANDU PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 86 | 624.1% | |
Low | Rs | 272 | 50 | 541.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 67.6 | 558.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.6 | 1,505.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 2.1 | 1,496.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0.75 | 533.3% | |
Avg Dividend yield | % | 1.0 | 1.1 | 89.8% | |
Book value per share (Unadj.) | Rs | 256.8 | 40.6 | 632.2% | |
Shares outstanding (eoy) | m | 58.71 | 9.66 | 607.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.0 | 106.3% | |
Avg P/E ratio | x | 17.1 | 43.3 | 39.4% | |
P/CF ratio (eoy) | x | 12.8 | 32.3 | 39.7% | |
Price / Book Value ratio | x | 1.6 | 1.7 | 93.9% | |
Dividend payout | % | 16.9 | 47.6 | 35.4% | |
Avg Mkt Cap | Rs m | 23,743 | 658 | 3,607.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 111 | 1,516.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 653 | 3,392.7% | |
Other income | Rs m | 256 | 3 | 7,831.8% | |
Total revenues | Rs m | 22,427 | 657 | 3,414.8% | |
Gross profit | Rs m | 2,257 | 25 | 9,077.6% | |
Depreciation | Rs m | 462 | 5 | 8,928.4% | |
Interest | Rs m | 165 | 1 | 20,587.5% | |
Profit before tax | Rs m | 1,887 | 22 | 8,509.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 7 | 7,113.5% | |
Profit after tax | Rs m | 1,391 | 15 | 9,147.9% | |
Gross profit margin | % | 10.2 | 3.8 | 267.6% | |
Effective tax rate | % | 26.2 | 31.4 | 83.6% | |
Net profit margin | % | 6.3 | 2.3 | 269.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 255 | 3,784.1% | |
Current liabilities | Rs m | 5,025 | 139 | 3,619.7% | |
Net working cap to sales | % | 20.9 | 17.8 | 117.3% | |
Current ratio | x | 1.9 | 1.8 | 104.5% | |
Inventory Days | Days | 43 | 65 | 66.9% | |
Debtors Days | Days | 8 | 268 | 3.1% | |
Net fixed assets | Rs m | 11,017 | 286 | 3,849.4% | |
Share capital | Rs m | 587 | 97 | 607.7% | |
"Free" reserves | Rs m | 14,490 | 296 | 4,898.6% | |
Net worth | Rs m | 15,077 | 392 | 3,842.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 542 | 3,818.6% | |
Interest coverage | x | 12.5 | 28.7 | 43.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.2 | 88.8% | |
Return on assets | % | 7.5 | 3.0 | 254.7% | |
Return on equity | % | 9.2 | 3.9 | 238.2% | |
Return on capital | % | 13.6 | 5.9 | 232.5% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2 | 55,325.8% | |
From Investments | Rs m | -1,200 | 5 | -22,346.4% | |
From Financial Activity | Rs m | -41 | 6 | -709.8% | |
Net Cashflow | Rs m | -18 | 13 | -137.6% |
Indian Promoters | % | 48.2 | 42.9 | 112.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 17,000.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 57.1 | 90.7% | |
Shareholders | 130,003 | 10,001 | 1,299.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SANDU PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.71% | -1.85% | 1.03% |
1-Month | 6.55% | 5.60% | 1.10% |
1-Year | 1.45% | 8.18% | 53.75% |
3-Year CAGR | -12.66% | 6.80% | 14.67% |
5-Year CAGR | 16.39% | 23.71% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SANDU PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SANDU PHARMA the stake stands at 42.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SANDU PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SANDU PHARMA paid Rs 0.8, and its dividend payout ratio stood at 47.6%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SANDU PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.